Form 8-K · Current report
News Corp 8-K, filed Aug 27, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000189
Summary
News Corp disclosed to the Australian Securities Exchange that it repurchased 50,801 Class A common shares for about US$1.57 million on August 26, 2026, under its 2025 repurchase program, and has bought back roughly US$446.1 million of Class A and Class B stock against the program's US$1 billion authorization.
Key points
- The repurchase program, authorized July 15, 2025, allows up to US$1 billion in aggregate of Nasdaq-listed Class A and Class B common stock; no ASX-listed CDIs will be repurchased.
- Shares bought back on August 26, 2026 were purchased at prices between US$30.76 and US$31.045.
- Cumulative purchases under the program total approximately US$446.1 million based on total consideration paid.
- The buy-back is funded in cash in US dollars and does not require security holder approval.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.